3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
9
Squamous Cell Carcinoma of Head and Neck
4
Nasopharyngeal Carcinoma
4
Esophageal Squamous Cell Carcinoma
4
Carcinoma, Non-Small-Cell Lung
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Esophageal Neoplasms
3
Pancreatic Neoplasms
2
Locally Advanced Rectal Cancer
2
Colonic Neoplasms
2
Cervical Cancer Metastatic
2
Breast Neoplasms
2
Adenocarcinoma
2
Turcot syndrome
1
Salivary Gland Neoplasms
1
Recurrence
1
Rectal Cancer Patients
1
Non-squamous Non-small-cell Lung Cancer
1
Mouth Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Laryngeal Neoplasms
1
Gestational Trophoblastic Disease
1
Esophageal Squamour Cell Cancer
1
Endometrioid Endometrial Cancer
1
Colorectal Neoplasms
1
Biliary Tract Neoplasms
1
Advanced Primary Liver Cancer
1
Interventions
Magnetic Resonance Spectroscopy
13
Cisplatin
12
Specimen Handling
11
pembrolizumab
10
Radiotherapy, Intensity-Modulated
7
Cetuximab
7
Platinum
6
1,2-diaminocyclohexaneplatinum II citrate
6
Taxes
4
Surgical Procedures, Operative
4
Radiotherapy
4
Paclitaxel
4
Carboplatin
4
Biopsy
4
(225)Ac-DOTA-c(RGDyK)
4
Radiation
3
Chemoradiotherapy
3
ipatasertib
2
X-Rays
2
Surveys and Questionnaires
2
Interviews as Topic
2
Immunoglobulin G
2
Fluorodeoxyglucose F18
2
Docetaxel
2
Disulfides
2
sacituzumab govitecan
1
peposertib
1
merphos
1
durvalumab
1
dehydroftorafur
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hypopharyngeal Neoplasms
×
camrelizumab
×
1 year
×
Clear all
No trials found.